1 |
Mirmosayyeb O, Ghaffary EM, Bagherieh S, Barzegar M, Dehghan MS, Shaygannejad V. Post COVID-19 Infection Neuromyelitis Optica Spectrum Disorder (NMOSD): A Case Report-Based Systematic Review. Multiple Sclerosis and Related Disorders 2022. [DOI: 10.1016/j.msard.2022.103697] [Reference Citation Analysis]
|
2 |
Kaklamanos A, Belogiannis K, Skendros P, Gorgoulis VG, Vlachoyiannopoulos PG, Tzioufas AG. COVID-19 Immunobiology: Lessons Learned, New Questions Arise. Front Immunol 2021;12:719023. [PMID: 34512643 DOI: 10.3389/fimmu.2021.719023] [Reference Citation Analysis]
|
3 |
Goldman M, Hermans C. Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity. PLoS Med 2021;18:e1003648. [PMID: 34029337 DOI: 10.1371/journal.pmed.1003648] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
4 |
Calabrese L, Winthrop KL. Rheumatology and COVID-19 at 1 year: facing the unknowns. Ann Rheum Dis 2021:annrheumdis-2021-219957. [PMID: 33658236 DOI: 10.1136/annrheumdis-2021-219957] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
|
5 |
Gracia-Ramos AE, Martin-Nares E, Hernández-Molina G. New Onset of Autoimmune Diseases Following COVID-19 Diagnosis. Cells 2021;10:3592. [PMID: 34944099 DOI: 10.3390/cells10123592] [Reference Citation Analysis]
|
6 |
Hosseini P, Fallahi MS, Erabi G, Pakdin M, Zarezadeh SM, Faridzadeh A, Entezari S, Ansari A, Poudineh M, Deravi N. Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities. Front Mol Biosci 2022;9:804109. [DOI: 10.3389/fmolb.2022.804109] [Reference Citation Analysis]
|